EXFY

SEC filing EXFY Regains Nasdaq Listing Compliance After 30-Day Deficiency, Stock Holds $1.00+ for 10 Consecutive Days

3d ago

Insider trade Sale by Alvarez Divo Carlos Eduardo

4d ago

News Expensify CEO Barrett unloads $74,398 in company stock By Investing.com - Investing.com

14d ago

News Expensify (EXFY) Upgraded to Buy: Here's Why

14d ago

News Expensify starts modified Dutch auction for up to $25M stock buyback

20d ago

Insider trade Sale by David Michael Barrett (Chief Executive Officer)

21d ago

News Expensify EXFY Q1 2026 Earnings Transcript

25d ago

Insider trade Sale by Divo Carlos Eduardo Alvarez

32d ago

SEC filing EXFY Deficiency Letter: $1.00 Bid Price Below Nasdaq Minimum, 180-Day Cure Window Until Oct 14 2026, Potential Reverse Split Ratios 1:15, 1:20, 1:25 Approved at May 22 Annual Meeting

41d ago

Insider trade Purchase by McLaughlin Steven J. / Steven J. McLaughlin Revocable Trust / EXP 2020 SPV LP / SF Roofdeck GP LLC

75d ago

Insider trade Sale by David Michael Barrett (Chief Executive Officer)

90d ago

News Expensify outlines $6M–$9M free cash flow guidance for 2026 amid expanded AI investment and sales push

95d ago

Insider trade Sale by David Michael Barrett (Chief Executive Officer)

104d ago

Scanner Unusual volume (2.3x average)

118d ago